TuHURA BIOSCIENCES, INC./NV Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TuHURA BIOSCIENCES, INC./NV share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 35.78K shares.
- TuHURA BIOSCIENCES, INC./NV share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 0.00 shares.
- TuHURA BIOSCIENCES, INC./NV share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 307.63K shares, a 70.26% increase from fiscal 2024.
- TuHURA BIOSCIENCES, INC./NV share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 180.69K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | 35.78K shares derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-15 | 41.15K shares derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | 35.78K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 307.63K shares 10-K · filed 2026-03-31 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | |
| 2025-06-30 | 5.37K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | |
| 2025-03-31 | 266.49K shares 10-Q · filed 2025-05-15 | |
| 2024-12-31 | 180.69K shares 10-K · filed 2025-03-31 | |
| 2023-03-31 | -43.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11 | |
| 2019-09-30 | 1.25K shares 10-Q · filed 2019-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |